CRISPR Technology Market

CRISPR Technology Market Size, Share & Trends Analysis Report, By Application (Biomedical Applications, Agricultural Applications, and Industrial Applications), By End-User (Pharmaceutical & Biopharmaceutical Companies and Academic & Research Institutes), and Forecast 2019-2025
    Update Available - Forecast 2024-2030   

Published: Jul 2023 | Report Code: | Category : Biotechnology | Delivery Format: /

The global CRISPR technology market is expected to witness a growth rate of 27.1% during the forecast period. The market growth is attributed to increasing government and private funding and rising demand for CRISPR coupled with advancement in technology. Further, the players operating in the market are contributing a significant share to enhance the CRISPR technology market size. For instance, in 2018, Colorado-based biotech, Inscripta acquired Solana Biosciences to ramp up the commercialization of its gene-editing technology. The acquisition is aimed at broadening access to CRISPR by offering new enzymes for free and for boosting CRISPR research by outfitting scientists with a full suite of tools.

CRISPR has wide applications in genome engineering, RNA editing, Gene drive, Gene function, In- Vitro genetic depletion, biomedicines, disease models and many more. Widespread applications of CRISPR is another major factor spurring the growth of the global CRISPR technology market. However, there are certain factors that are hampering the growth of the market. Patent infringement and ethical issues associated with the misuse of CRISPR gene editing tools are estimated to be the major restraint in the growth of the market.

Segmental Outlook  

The global CRISPR technology market is segmented on the basis of application and end-user. Based on application, the market is segmented into biomedical applications, agricultural applications, and industrial applications. Further, on the basis of end-user, the market is bifurcated into pharmaceutical & biopharmaceutical companies and academic & research institutes.

CRISPR Market Share by Application, 2018 (%)

CRISPR Market Share by Application

Application Insights: Biomedical Application to Have Significant Share During the Forecast Period

The major biomedical applications of the CRISPR technology include drug discovery, gene therapy, and diagnostics. The increase in clinical trials of gene therapy across the globe is one of the major factors driving the segmental growth of the market. CRISP technology in drug discovery is used for developing more physiologically relevant models such as cell lines models that correlate better to the clinical setting and hence results in the reduction of the failure of a drug candidate in the initial steps.

Regional Outlook 

Moreover, the market is geographically segmented into North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific) and Rest of the World (RoW). North America is estimated to be the leading region in the global CRISPR technology market owing to its high number of R&D activities in the region. In North America, the US dominates the CRISPR technology market driven by the development of the pharmaceutical and biotechnology industry which in turn will benefit the CRISPR market.

CRISPR Technology Market Growth, by Region 2019-2025

CRISPR Technology Market Growth, by Region

Asia-Pacific is Estimated to Exhibit Considerable Growth in the Market

The CRISPR technology market is rapidly expanding in the Asia-Pacific and is witnessing a significant growth specifically in the countries including China, India, and Japan. The growth in the region is attributed to the increasing number of drug discovery activities across the region. Increasing penetration of prominent pharmaceutical companies in the region is further anticipated to increase the growth rate of the market in the Asia-Pacific region. According to the International Diabetes Federation, 82 million people in the Southeast Asia Region are diagnosed with diabetes. CRISPR has the potential to cure diabetes and countries such as Japan China and India are investing heavily in the research for the treatment of diabetes using CRISPR technology.

Market Players Outlook

The major players that contribute to the growth of the market include Thermo Fisher Scientific Inc., Merck KGaA, GenScript Biotech Corp., Horizon Discovery Group PLC, CRISPR Therapeutics AG, and others. These market players are contributing to the market by adopting various market approaches including product launch and approvals, merger and acquisition, partnerships and collaborations, and others for gaining a strong position in the market.

Recent Developments 

  • In July 2019, University of California (UC), University of Vienna, and Dr. Emmanuelle Charpentier has been awarded patents by the US Patent and Trademark Office (USPTO). The patent will cover the use method for producing a genetically modified cell through the introduction of the Cas9 protein, or a nucleic acid encoding the Cas9 protein, as well as a single-molecule DNA-targeting RNA in a cell.
  • In March 2018, Danaher Corp. acquired Integrated DNA Technologies. Integrated DNA Technologies is engaged in manufacturing high-quality, custom DNA and RNA oligonucleotides. The acquisition enabled Danaher Corp. to expand the presence in the genomics market. This will also enable the company to accelerate the research as they are engaged in the development of critical diagnostic tests and potential life-saving therapies.
  • In July 2017, Horizon Discovery Group PLC acquired GE Healthcare Dharmacon for $85 million. The combined company created as a result of this acquisition is focused on applying gene-editing and gene-modulation technologies in life science research.

The Report Covers

  • Market value data analysis of 2018 and forecast to 2025.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global CRISPR technology market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying ‘who-stands-where’ in the market.

1. Report Summary 

1.1. Research Methods and Tools

1.2. Market Breakdown 

1.2.1. By Segments

1.2.2. By Geography

2. Market Overview and Insights

2.1. Scope of the Report 

2.2. Analyst Insight & Current Market Trends

2.2.1. Key Findings

2.2.2. Recommendations

2.2.3. Conclusion

2.3. Rules & Regulations

3. Competitive Landscape

3.1. Company Share Analysis

3.2. Key Strategy Analysis

3.3. Key Company Analysis 

3.3.1. Thermo Fisher Scientific, Inc. 

3.3.1.1. Overview

3.3.1.2. Financial Analysis

3.3.1.3. SWOT Analysis

3.3.1.4. Recent Developments

3.3.2. Merck KGaA

3.3.2.1. Overview

3.3.2.2. Financial Analysis

3.3.2.3. SWOT Analysis

3.3.2.4. Recent Developments

3.3.3. GenScript Biotech Corp.

3.3.3.1. Overview

3.3.3.2. Financial Analysis

3.3.3.3. SWOT Analysis

3.3.3.4. Recent Developments

3.3.4. Horizon Discovery Group PLC

3.3.4.1. Overview

3.3.4.2. Financial Analysis

3.3.4.3. SWOT Analysis

3.3.4.4. Recent Developments

3.3.5. CRISPR Therapeutics AG

3.3.5.1. Overview

3.3.5.2. Financial Analysis

3.3.5.3. SWOT Analysis

3.3.5.4. Recent Developments

4. Market Determinants

4.1. Motivators

4.2. Restraints

4.3. Opportunities

5. Market Segmentation

5.1. CRISPR Technology Market by Application

5.1.1. Biomedical Applications

5.1.2. Agricultural Applications

5.1.3. Industrial Applications

5.2. Global CRISPR Technology Market by End-User

5.2.1. Pharmaceutical and Biopharmaceutical Companies

5.2.2. Academic & Research Institutes

6. Regional Analysis

6.1. North America

6.1.1. United States

6.1.2. Canada

6.2. Europe

6.2.1. UK

6.2.2. Germany

6.2.3. Italy

6.2.4. Spain

6.2.5. France

6.2.6. Rest of Europe

6.3. Asia-Pacific

6.3.1. China

6.3.2. India

6.3.3. Japan

6.3.4. Rest of Asia-Pacific

6.4. Rest of the World

7. Company Profiles

7.1. AstraZeneca PLC

7.2. BASF SE

7.3. Beam Therapeutics Inc.

7.4. Bio-Rad Laboratories, Inc.

7.5. Caribou Bioscience Inc.

7.6. Cellectics SA

7.7. Cibus, Ltd.

7.8. CRISPR Therapeutics AG

7.9. Danaher Corp.

7.10. Editas Medicine

7.11. GeneCopoeia inc.

7.12. GenScript Biotech Corp.

7.13. Horizon Discovery Group PLC

7.14. Intellia Therapeutics Inc.

7.15. Lonza Group Ltd.

7.16. Merck KGaA

7.17. New England Biolabs, Inc.

7.18. Origene Technologies, Inc.

7.19. Pairwise Plants

7.20. Precision Bioscience, Inc.

7.21. Sangamo Therapeutics Inc.

7.22. Thermo Fisher Scientific, Inc.

7.23. Transposagen Biopharmaceuticals, Inc.

7.24. Tropic Biosciences UK LTD.

7.25. Yield10 Bioscience, Inc.

GLOBAL CRISPR TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)

2. GLOBAL CRISPR FOR BIOMEDICAL APPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

3. GLOBAL CRISPR FOR AGRICULTURAL APPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

4. GLOBAL CRISPR FOR INDUSTRIAL APPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

5. GLOBAL CRISPR TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)

6. GLOBAL CRISPR IN PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

7. GLOBAL CRISPR IN ACADEMIC & RESEARCH INSTITUTES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)

8. GLOBAL CRISPR TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)

9. NORTH AMERICAN CRISPR TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)

10. NORTH AMERICAN CRISPR TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)

11. NORTH AMERICAN CRISPR MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)

12. EUROPEAN CRISPR TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)

13. EUROPEAN CRISPR TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)

14. EUROPEAN CRISPR TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)

15. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)

16. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)

17. ASIA-PACIFIC CRISPR TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY END-USER 2018-2025 ($ MILLION)

18. REST OF THE WORLD CRISPR TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)

19. REST OF THE WORLD CRISPR TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)

1. GLOBAL CRISPR TECHNOLOGY MARKET SHARE BY APPLICATION, 2018 VS 2025 (%)

2. GLOBAL CRISPR TECHNOLOGY MARKET SHARE BY END-USER, 2018 VS 2025 (%)

3. GLOBAL CRISPR TECHNOLOGY MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)

4. US CRISPR TECHNOLOGY MARKET SIZE, 2018-2025 ($ MILLION)

5. CANADA CRISPR TECHNOLOGY MARKET SIZE, 2018-2025 ($ MILLION)

6. UK CRISPR TECHNOLOGY MARKET SIZE, 2018-2025 ($ MILLION)

7. FRANCE CRISPR TECHNOLOGY MARKET SIZE, 2018-2025 ($ MILLION)

8. GERMANY CRISPR TECHNOLOGY MARKET SIZE, 2018-2025 ($ MILLION)

9. ITALY CRISPR TECHNOLOGY MARKET SIZE, 2018-2025 ($ MILLION)

10. SPAIN CRISPR TECHNOLOGY MARKET SIZE, 2018-2025 ($ MILLION)

11. REST OF EUROPE CRISPR TECHNOLOGY MARKET SIZE, 2018-2025 ($ MILLION)

12. INDIA CRISPR TECHNOLOGY MARKET SIZE, 2018-2025 ($ MILLION)

13. CHINA CRISPR TECHNOLOGY MARKET SIZE, 2018-2025 ($ MILLION)

14. JAPAN CRISPR TECHNOLOGY MARKET SIZE, 2018-2025 ($ MILLION)

15. REST OF ASIA-PACIFIC CRISPR TECHNOLOGY MARKET SIZE, 2018-2025 ($ MILLION)

16. REST OF THE WORLD CRISPR TECHNOLOGY MARKET SIZE, 2018-2025 ($ MILLION)